Literature DB >> 11278749

Rab8b and its interacting partner TRIP8b are involved in regulated secretion in AtT20 cells.

S Chen1, M C Liang, J N Chia, J K Ngsee, A E Ting.   

Abstract

Rab proteins are a family of small GTPases that regulate intracellular vesicle traffic. Rab8b, because of its homology with Rab8, has been suggested to function in vesicle transport to the plasma membrane. Using the yeast two-hybrid system, we identified a Rab8b interacting clone, termed TRIP8b, from a rat brain cDNA library. The gene encodes a 66-kDa protein with homology to the peroxisomal targeting signal 1 receptor. The interaction between Rab8b and TRIP8b was further verified by in vitro binding assays and co-immunoprecipitation studies. Additional experiments with Rab8b mutants demonstrated that Rab8b requires a guanine nucleotide but not prenylation for its interaction with TRIP8b. Western immunoblot analysis showed that TRIP8b was primarily expressed in brain. Subcellular fractionation of AtT20 cells revealed that TRIP8b was present in both cytosolic and membrane fractions. To investigate the function of Rab8b and TRIP8b in secretion, we examined the release of ACTH from AtT20 cells. Results from stable cell lines expressing Rab8b or TRIP8b indicated that both proteins had a stimulatory effect on cAMP-induced secretion of ACTH. In summary, these data suggest that Rab8b and TRIP8b interact with each other and are involved in the regulated secretory pathway in AtT20 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278749     DOI: 10.1074/jbc.M010798200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  A Rab8-specific GDP/GTP exchange factor is involved in actin remodeling and polarized membrane transport.

Authors:  Katarina Hattula; Johanna Furuhjelm; Airi Arffman; Johan Peränen
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

2.  RAB8 enhances TMEM205-mediated cisplatin resistance.

Authors:  Ding-Wu Shen; Michael M Gottesman
Journal:  Pharm Res       Date:  2011-10-04       Impact factor: 4.200

3.  Interaction of calcium-independent latrotoxin receptor with intracellular adapter protein TRIP8b.

Authors:  N V Popova; A Plotnikov; I E Deev; A G Petrenko
Journal:  Dokl Biochem Biophys       Date:  2007 May-Jun       Impact factor: 0.788

4.  The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells.

Authors:  Liyun Zou; Jingran Zhou; Jinyu Zhang; Jingyi Li; Na Liu; Linlin Chai; Na Li; Ting Liu; Liqi Li; Zhunyi Xie; Hongli Liu; Ying Wan; Yuzhang Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

5.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 6.  Role of Rab GTPases in membrane traffic and cell physiology.

Authors:  Alex H Hutagalung; Peter J Novick
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 7.  HCN channelopathies: pathophysiology in genetic epilepsy and therapeutic implications.

Authors:  Christopher A Reid; A Marie Phillips; Steven Petrou
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

8.  Identification of PEX5p-related novel peroxisome-targeting signal 1 (PTS1)-binding proteins in mammals.

Authors:  L Amery; H Sano; G P Mannaerts; J Snider; J Van Looy; M Fransen; P P Van Veldhoven
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

9.  Association of adaptor protein TRIP8b with clathrin.

Authors:  Nadezhda V Popova; Igor E Deyev; Alexander G Petrenko
Journal:  J Neurochem       Date:  2011-08-12       Impact factor: 5.372

Review 10.  Searching for new targets for treatment of pediatric epilepsy.

Authors:  Yoav Noam; Yogendra H Raol; Gregory L Holmes
Journal:  Epilepsy Behav       Date:  2012-12-06       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.